Canine mammary tumor clinical parameters predict outcome.
- Ashley Case (201335)
- Becky K. Brisson (306176)
- Amy C. Durham (4229776)
- Suzanne Rosen (4229779)
- James Monslow (4229761)
- Elizabeth Buza (4229788)
- Pascale Salah (4229770)
- Julie Gillem (4229791)
- Gordon Ruthel (146575)
- Sridhar Veluvolu (4229773)
- Veronica Kristiansen (4229782)
- Ellen Puré (4229764)
- Dorothy C. Brown (4229767)
- Karin U. Sørenmo (4229785)
- Susan W. Volk (3932429)
Publication date
July 2017
DOIAbstract
<p>Kaplan-Meier survival curves and Cox regression univariate analysis was used to evaluate whether clinical parameters significantly impacted survival. A. Grade: grade I/II vs. grade III mammary tumors (p<0.001, hazard ratio (HR) 10.106, 95%CI 3.071–33.254). B. Stage: Stage 1/2 vs. 3/4 mammary tumors (p = 0.042, HR 2.778, 95%CI 1.039–7.420). C. Lymphovascular Invasion: Evidence vs. No Evidence (p<0.001, HR 7.462, 95%CI 2.359–23.603). D. Excision Completeness: Complete vs. Incomplete (p = 0.014, HR 4.255, 95%CI 1.335–13.558). E. OHE: At time of excision vs. prior to excision or not performed (p = 0.009, HR 0.133, 95%CI 0.029–0.604).</p
Add to ORKG